Phase 1 Bone Metastases Clinical Trials

4 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–4 of 4 trials

Recruiting

Phase 1

Samarium Optimized for Long-lasting Analgesia in Cancerous End-stage Bone Pain

Bone PainMetastatic Bone TumorBone Metastases in Subjects With Advanced Cancer

Telix Pharmaceuticals (Innovations) Pty Limited33 enrolled3 locationsNCT07197645

Recruiting

Phase 1

Safety Study for a Gamma Delta T Cell Product Used With Low Dose Radiotherapy in Patients With Locally Advanced or Metastatic NSCLC or Solid Tumors With Bone Metastases

Carcinoma, Non-Small-Cell Lung CancerBone Metastases From Solid Tumors

Kiromic BioPharma Inc.48 enrolled5 locationsNCT06069570

Recruiting

Phase 1Phase 2

Single Arm Phase II Study of Fractionated Stereotatic Radiation Therapy (FSRT) for Bone Metastases in Breast Cancer

Breast CancerBone Metastases

Fudan University120 enrolled1 locationNCT04947280

Terminated

Phase 1

A Phase 1 Trial of ALMB-0168 in Patients with Malignant Bone Disease

Osteosarcoma or any other solid tumor cancer with bone metastases

Avance Clinical Pty Ltd35 enrolled3 locationsACTRN12620000440921